Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05889637 · ClinicalTrials.gov registry record
Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists
A clinical trial, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- 132
- Enrollment target
NCT05889637: Completed study, sponsored by The University of Texas Health Science Center, Houston.
NCT05889637 is a clinical trial that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05889637 has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the type of gastric content and quantify the volume of liquid gastric contents using ultrasonography in patients on GLP-1 agonists that have presented for elective surgery and to determine if risk factors are associated with a higher gastric volume in patients on GLP-1 receptor agonists.
Primary Outcome
Risk for aspiration is indicated by the presence of solids, thick fluid, or clear fluids \>1.5ml/kg in the gastric antrum in the right lateral decubitus position
Interventions
- DIAGNOSTIC_TEST Gastric ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2023-06-06 |
| Est. Completion | 2023-07-12 |
What the finished NCT05889637 record still lists
NCT05889637 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Gastric ultrasound is the first listed.
NCT05889637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05889637 about?
NCT05889637 is a clinical study titled "Gastric Ultrasound Assessment for Preoperative Prandial State of Patients Taking Glucagon-Like Peptide-1 Receptor Agonists". The purpose of this study is to determine the type of gastric content and quantify the volume of liquid gastric contents using ultrasonography in patients on GLP-1 agonists that have presented for elective surgery and to determine if risk factors are associated with a higher gastric volume in patien...
What is the current status of trial NCT05889637?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2023-06-06. Estimated completion is 2023-07-12.
What interventions are being tested in trial NCT05889637?
The interventions under investigation include: Gastric ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05889637?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI